Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „section“
Suchtreffer
Begriffe & Kennungen
A. carotis, interne Dissektion
Eintrag öffnenA. vertebralis-Dissektion
Eintrag öffnenAbasaglar (previously Abasria) · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAbasaglar (previously Abasria) · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAbilify Maintena · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAbilify Maintena · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAbilify Maintena · 4.8 · Weight During the double-blind, active-controlled phase of the 38-week long-term trial (see section 5.1), the
Eintrag öffnenAbilify Maintena · 4.8 · Weight During the double-blind, active-controlled phase of the 38-week long-term trial (see section 5.1), the
Eintrag öffnenAbiraterone Mylan · 4.3 · • Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. • Women who are
Eintrag öffnenAblymico · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAblymico · 4.8 · Cutaneous amyloidosis Cutaneous amyloidosis may occur at the injection site (see section 4.2).
Eintrag öffnenAbraxane · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAbraxane · 4.3 · Lactation (see section 4.6).
Eintrag öffnenAbraxane · 4.8 · This section contains the most common and clinically relevant adverse reactions related to Abraxane.
Eintrag öffnenAbrysvo · 4.3 · Hypersensitivity to the active substances or to any of the excipients listed in section 6.1.
Eintrag öffnenAbseamed · 4.3 · - Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAclasta · 4.3 · - Patients with hypocalcaemia (see section 4.4).
Eintrag öffnenAclasta · 4.3 · - Pregnancy and breast-feeding (see section 4.6).
Eintrag öffnenAclasta · 4.3 · - Severe renal impairment with creatinine clearance < 35 ml/min (see section 4.4).
Eintrag öffnenAclasta · 4.8 · Atrial fibrillation In the HORIZON – Pivotal Fracture Trial [PFT] (see section 5.1), the overall incidence of
Eintrag öffnen